Date of this Version
10-17-2009
Document Type
Journal Article
Abstract
Extract:
Oseltamivir is a successful drug: between July, 2004, and June, 2009, more than 11·5 million new prescriptions were issued in the USA, and nearly all influenza pandemic plans recommend antiviral drugs as a mainstay of containment on a population basis and treatment on an individual basis, with oseltamivir preferred because of ease of administration and storage. Because 75% of the world production of oseltamivir has been used in Japan,¹ this is where to look for any serious harms the drug might cause.
¹ See note in article.
This document has been peer reviewed.
Publication Details
Accepted Version.
Jefferson, T., Jones, M., Doshi, P. & Del Mar, C. (2009). Possible harms of oseltamivir—A call for urgent action. The lancet, 374(9698), 1312-1313.
Access the publisher's website.
© Copyright Elsevier Ltd, 2009